Home » Services » Autoimmune Disease Animal Models-Small Animals » Blood » Idiopathic thrombocytopenic purpura

loading

Idiopathic thrombocytopenic purpura

Availability:
Quantity:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
kakao sharing button
snapchat sharing button
sharethis sharing button

Idiopathic Thrombocytopenic Purpura

● Symptoms and Causes  

Idiopathic thrombocytopenic purpura is a blood disorder characterized by an abnormal decrease in the number of platelets in the blood. Platelets are cells in the blood that help stop bleeding. A decrease in platelets can result in easy bruising, bleeding gums and internal bleeding. ITP occurs when certain immune system cells produce antibodies against platelets. Platelets help your blood clot by clumping together to plug small holes in damaged blood vessels. The antibodies attach to the platelets. The body destroys the platelets that carry the antibodies.

Symptoms may include: petechiae, purpura, bruises, bleeding gums, blood in poop (stool), blood in urine (pee),  heavy menstrual periods, heavy nosebleeds, hematoma (large bruise).

jcm-06-00016-v2-6

Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP). J. Clin. Med. 2017, 6, 16.


 ● Models in place 【Date➡Models】

Anti-CD41 antibody Induced ITP Model

【Mechanism】From among several passive antibody transfer ITP models developed, most laboratories utilize the anti-CD41antibody model, which is based on a self-antigen that is highly relevant to the human disorder. The infusion of the anti-CD41 antibody leads to a rapid onset ITP with clear involvement of the phagocytic monocytes in platelet destruction. The passive antibody transfer-induced ITP model also offers a degree of tunability, allowing for the severity and persistence of the ITP to be controlled by adjusting the  dosage and frequency of the antiplatelet antibody administered. Repeat administration of the anti-CD41 antibody, with a dose-escalation regimen, maintains a prolonged thrombocytopenia that closely resembles chronic human ITP.

5456d841691de3886e4677f977930d4

0d9bde524fc07a960d9ca95f84f121b

3afd07756a09341d7674d78f0f310b5




Previous: 
Next: 
HKeybio is a Contract Research Organization (CRO) specializing in preclinical research within the field of autoimmune diseases.

Quick Links

Service Catagory

Contact Us

   Tel: +86-512-67485716
  Phone: +86-18051764581
  info@hkeybio.com
  Add: Building B, No.388 Xingping Street, Ascendas iHub Suzhou Industrial Park, JIANGSU, CHINA
Leave a Message
Contact Us
 Subscribe
Sign up for our newsletter to receive the latest news.
​Copyright © 2024 HkeyBio. All rights reserved. | Sitemap | Privacy Policy